Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis.

Yong-Kuan Jiang, Hai-Yan Deng, Zeng-Yong Qiao, Fang-Xiao Gong

Journal: Archives of physiology and biochemistry 2024;127(5):468-478

PMID: 33476191

Abstract

It is reported that elevated visfatin level is associated with gestational diabetes mellitus (GDM). However, the relationship between visfatin level and GDM remains controversial. The aim of our study was to systematically review available literature linking visfatin to GDM for a comprehensive understanding of the relationship between circulating visfatin level and GDM in human. PubMed, The Cochrane Library and Web of Science were searched for studies published up to July 2020. Standard mean difference with 95% confidence interval was calculated to evaluate the relationship between visfatin level and GDM using the Review Manager 5.3 and Stata 12.0. The evidence indicated that no significant difference was observed in the level of circulating visfatin between the women with GDM and normal glucose tolerance, suggesting circulating visfatin level is not independently related to GDM. Nevertheless, visfatin is involved in the development of GDM in obese women.

Address: Department of Anesthesiology, Ningbo No.6 Hospital, Ningbo, China.; Department of Cardiovascular Medicine, Southern Medical University Affiliated Fengxian Hospital, Shanghai, China.; Department of Critical Care Medicine, Zhejiang Provincial People's Hospital and People's Hospital of Hangzhou Medical College, Hangzhou, China.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.